News for Amylyx Pharmaceuticals Stock (AMLX)

Class Action Filed Against Amylyx Pharmaceuticals, Inc. (AMLX) Seeking Recovery for Investors - Contact Levi & Korsinsky

Accesswire • 04/05/24

Amylyx Pharmaceuticals, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – AMLX

Accesswire • 04/04/24

AMLX FINAL DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Amylyx Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 9 Deadline in Securities Class Action - AMLX

PRNewsWire • 04/04/24

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 9, 2024 in Amylyx Lawsuit - AMLX

Accesswire • 04/04/24

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Amylyx Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - AMLX

PRNewsWire • 04/04/24

Amylyx (AMLX) Withdraws ALS Drug, Cuts Workforce by 70%

Zacks Investment Research • 04/04/24

Levi & Korsinsky Reminds Amylyx Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 9, 2024 - AMLX

Accesswire • 04/04/24

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Amylyx

PRNewsWire • 04/04/24

Amylyx Is Cutting 70% of Its Workforce and Pulling ALS Drug From the Market

Barrons • 04/04/24

Levi & Korsinsky Reminds Amylyx Pharmaceuticals, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 9, 2024 - AMLX

Accesswire • 04/04/24

Amylyx Pharmaceuticals to remove ALS drug from US, Canada markets

Reuters • 04/04/24

Amylyx Pharmaceuticals Announces Formal Intention to Remove RELYVRIO®/ALBRIOZA™ from the Market; Provides Updates on Access to Therapy, Pipeline, Corporate Restructuring, and Strategy

Business Wire • 04/04/24

Shareholders that lost money on Amylyx Pharmaceuticals, Inc.(AMLX) should contact Levi & Korsinsky about pending Class Action - AMLX

Accesswire • 04/04/24

Amylyx Pharmaceuticals, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before April 9, 2024 to Discuss Your Rights - AMLX

Accesswire • 04/03/24

Shareholders of Amylyx Pharmaceuticals, Inc. Should Contact Levi & Korsinsky Before April 9, 2024 to Discuss Your Rights - AMLX

PRNewsWire • 04/03/24

Shareholders that lost money on Amylyx Pharmaceuticals, Inc. (AMLX) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More

Accesswire • 04/02/24

FINAL DEADLINE NEXT WEEK: The Schall Law Firm Encourages Investors in Amylyx Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm

Accesswire • 04/02/24

The Gross Law Firm Reminds Amylyx Pharmaceuticals, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 9, 2024 - AMLX

PRNewsWire • 04/02/24

Levi & Korsinsky Notifies Shareholders of Amylyx Pharmaceuticals, Inc. (AMLX) of a Class Action Lawsuit and an Upcoming Deadline

Accesswire • 04/02/24

VKTX, JANX and these biotech stocks are surging in 2024

Invezz • 04/02/24

Class Action Filed Against Amylyx Pharmaceuticals, Inc. (AMLX) Seeking Recovery for Investors – Contact Levi & Korsinsky

Accesswire • 04/02/24

FINAL DEADLINE IMMINENT: The Schall Law Firm Encourages Investors in Amylyx Pharmaceuticals, Inc. with Losses to Contact the Firm

Accesswire • 04/01/24

Class Action Filed Against Amylyx Pharmaceuticals, Inc. (AMLX) - April 9, 2024 Deadline to Join - Contact Levi & Korsinsky

Accesswire • 04/01/24

Shareholders that lost money on Amylyx Pharmaceuticals, Inc.(AMLX) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More

Accesswire • 03/31/24

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Amylyx Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm

Accesswire • 03/31/24